Supplemental Figure Legends from Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Cytotoxicity in Head and Neck Squamous Cell Carcinoma